Ishibashi Hideaki
Department of Orthopaedic Surgery, The Orthopaedic Institute for the Elderly, Japan.
Clin Calcium. 2012 Jun;22(6):890-5.
"The guideline for prevention and treatment of osteoporosis 2011" shows methods and precautions for evaluations of therapeutic effects of drugs for osteoporosis, in terms of bone mineral measurements, bone turnover markers, and vertebral deformities and fractures. Bone mineral measurements are effective, but responsible for just some part of the observed reduction in the risk of vertebral fracture. Bone turnover markers enable early and easy evaluations for the effectiveness of drugs, such as bone-resorption inhibitors or bone-formation accelerators. In particular, TRACP-5b and P1NP are user-friendly, because of small daily and day-to-day variations, as well as large amount of changes with therapy. SQ methods are well designed for X-ray evaluations of vertebral deformities and fractures with high convenience and reproducibility, good for not only epidemiological study, but daily practice.
《2011年骨质疏松症防治指南》展示了骨质疏松症药物治疗效果评估的方法及注意事项,涉及骨矿物质测量、骨转换标志物以及椎体畸形和骨折方面。骨矿物质测量是有效的,但仅能解释观察到的椎体骨折风险降低的部分原因。骨转换标志物能对诸如骨吸收抑制剂或骨形成促进剂等药物的疗效进行早期且简便的评估。特别是抗酒石酸酸性磷酸酶5b(TRACP-5b)和I型前胶原氨基端前肽(P1NP),因其每日及日间变化小,且治疗时变化量大,所以使用方便。脊柱X线摄影(SQ)方法针对椎体畸形和骨折的X线评估设计良好,具有高度的便利性和可重复性,不仅适用于流行病学研究,也适用于日常实践。